Cohen Klingenstein Portfolio holdings
Cohen Klingenstein is an investment adviser that manages portfolios for individuals, trusts, foundations and charities, and it advises one private fund, CK Diversified Fund. The fund began operating in 2013 for investors whose portfolios lack diversification, offering a way to spread their money more widely while limiting taxable gains. Its manager holds that owning a broad mix of securities for the long run can earn market-like returns at market-like risk, and the fund generally avoids sales that create a taxable gain. George Cohen and Thomas Klingenstein are the firm's principal owners.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$226K |
| 2 |
NVIDIA
NVDA
|
+$60.9K |
| 3 |
Vanguard Morningstar Growth ETF
VUG
|
+$32.4K |
| 4 |
Meta Platforms (Facebook)
META
|
+$25.6K |
| 5 |
Vanguard Morningstar Mid-Cap Growth ETF
VOT
|
+$18.6K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$11.6M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$6.51M |
| 3 |
iShares Russell 2000 Growth ETF
IWO
|
+$4.84M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$2.58M |
| 5 |
Electronic Arts
EA
|
+$1.83M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.43% |
| 2 | Technology | 17.29% |
| 3 | Communication Services | 8.78% |
| 4 | Healthcare | 8.3% |
| 5 | Financials | 7.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
151
Corteva
CTVA
$8.13B
| $1.12M | 0.03% |
14,378
| – | – |
2019 Q2
29 quarters
|
|
152
Air Products & Chemicals
APD
$69.5B
| $1.11M | 0.03% |
4,000
| – | – |
2019 Q3
28 quarters
|
|
153
Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund
ETW
$1.02B
| $1.09M | 0.03% |
114,690
| – | – |
2013 Q2
53 quarters
|
|
154
Ecolab
ECL
$86.1B
| $1.08M | 0.03% |
3,925
| – | – |
2018 Q2
33 quarters
|
|
155
Adobe
ADBE
$91.2B
| $1.07M | 0.03% |
4,452
| – | – |
2013 Q2
53 quarters
|
|
156
DELISTED
Warner Bros
WBD
| $1.04M | 0.03% |
33,756
| – | – |
2026 Q1
2 quarters
|
|
157
iShares MSCI Japan ETF
EWJ
$22.9B
| $1.02M | 0.03% |
10,500
| – | – |
2013 Q2
53 quarters
|
|
158
CVS Health
CVS
$111B
| $1M | 0.03% |
11,700
| – | – |
2019 Q1
30 quarters
|
|
159
eBay
EBAY
$54.1B
| $976K | 0.03% |
9,200
| – | – |
2013 Q2
53 quarters
|
|
160
Silicon Laboratories
SLAB
$7.38B
| $966K | 0.03% |
4,359
| – | – |
2013 Q2
53 quarters
|
|
161
Qnity Electronics Inc
Q
$25.3B
| $904K | 0.03% |
7,189
| – | – |
2025 Q4
3 quarters
|
|
162
Biogen
BIIB
$37.3B
| $904K | 0.03% |
4,000
| – | – |
2019 Q3
28 quarters
|
|
163
Fox Class A
FOXA
$28.2B
| $854K | 0.02% |
13,638
| – | – |
2019 Q1
30 quarters
|
|
164
Illumina
ILMN
$32.5B
| $821K | 0.02% |
3,000
| – | – |
2019 Q3
28 quarters
|
|
165
HP
HPQ
$25.4B
| $820K | 0.02% |
26,200
| – | – |
2015 Q2
45 quarters
|
|
166
Royal Caribbean
RCL
$90.3B
| $798K | 0.02% |
3,000
| – | – |
2023 Q2
13 quarters
|
|
167
Becton Dickinson
BDX
$58.1B
| $788K | 0.02% |
4,400
| – | – |
2013 Q2
53 quarters
|
|
168
Weyerhaeuser
WY
$14.9B
| $787K | 0.02% |
41,315
| – | – |
2019 Q1
30 quarters
|
|
169
Sempra
SRE
$51.2B
| $748K | 0.02% |
9,600
| – | – |
2021 Q3
20 quarters
|
|
170
Haleon
HLN
$39.7B
| $735K | 0.02% |
81,613
| – | – |
2022 Q3
16 quarters
|
|
171
GE HealthCare
GEHC
$37.8B
| $710K | 0.02% |
10,859
| – | – |
2023 Q1
14 quarters
|
|
172
Consolidated Edison
ED
$44.2B
| $705K | 0.02% |
6,900
| – | – |
2013 Q2
53 quarters
|
|
173
Nike
NKE
$57.6B
| $701K | 0.02% |
19,800
| – | – |
2019 Q2
29 quarters
|
|
174
InterDigital
IDCC
$7.36B
| $692K | 0.02% |
2,122
| – | – |
2023 Q4
11 quarters
|
|
175
Kimberly-Clark
KMB
$68.5B
| $682K | 0.02% |
7,000
| – | – |
2019 Q3
28 quarters
|
|
Similar funds
Cohen Klingenstein's Q3 2026 Portfolio in Review
As of Q3 2026, Cohen Klingenstein held 208 positions worth $3.51B, up 0.37% from $3.49B the previous quarter. Its ten largest holdings account for 63% of the portfolio.
Trading was light in Q3 2026: portfolio turnover was 1.4%. Cohen Klingenstein opened 1 new position and exited 2, leaving the 208-position portfolio largely intact.
By sector, the portfolio is most concentrated in Miscellaneous at 41% of assets, down from 43% a quarter earlier, followed by Technology and Communication Services.
- Cohen Klingenstein's largest Q3 2026 buy was Moderna: 2,100 shares worth $404K.
- Cohen Klingenstein added most to NVIDIA in Q3 2026, an estimated $60.9K increase.
- Cohen Klingenstein's biggest Q3 2026 reduction was Invesco QQQ Trust, cutting an estimated $11.6M.
- Cohen Klingenstein fully exited Electronic Arts in Q3 2026, selling an estimated $1.83M.
- Cohen Klingenstein's ten largest holdings make up 63% of its $3.51B portfolio in Q3 2026.
- Cohen Klingenstein opened 1 new position and closed 2 in Q3 2026.
- Cohen Klingenstein's portfolio value rose 0.37% quarter-over-quarter to $3.51B.
Based on Cohen Klingenstein's 13F filing for Q3 2026, filed 15 Oct 2026.